340 related articles for article (PubMed ID: 20969545)
1. T-cell agents in the treatment of rheumatoid arthritis.
Solomon GE
Bull NYU Hosp Jt Dis; 2010; 68(3):162-5. PubMed ID: 20969545
[TBL] [Abstract][Full Text] [Related]
2. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
3. [CTLA4-Ig (abatacept)].
Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1231-7. PubMed ID: 17642237
[TBL] [Abstract][Full Text] [Related]
4. Role of abatacept in the management of rheumatoid arthritis.
Nogid A; Pham DQ
Clin Ther; 2006 Nov; 28(11):1764-78. PubMed ID: 17212998
[TBL] [Abstract][Full Text] [Related]
5. Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):276-84. PubMed ID: 19228144
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
Isaacs JD
Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
[TBL] [Abstract][Full Text] [Related]
7. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
[No Abstract] [Full Text] [Related]
8. Safety profile of abatacept in rheumatoid arthritis: a review.
Khraishi M; Russell A; Olszynski WP
Clin Ther; 2010 Oct; 32(11):1855-70. PubMed ID: 21095481
[TBL] [Abstract][Full Text] [Related]
9. Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis.
Reynolds J; Shojania K; Marra CA
Pharmacotherapy; 2007 Dec; 27(12):1693-701. PubMed ID: 18041889
[TBL] [Abstract][Full Text] [Related]
10. Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis.
Shergy WJ
Semin Arthritis Rheum; 2009 Jun; 38(6):434-43. PubMed ID: 18538830
[TBL] [Abstract][Full Text] [Related]
11. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
Scheinfeld N
J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
[TBL] [Abstract][Full Text] [Related]
12. Drug Insight: abatacept for the treatment of rheumatoid arthritis.
Ruderman EM; Pope RM
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):654-60. PubMed ID: 17133250
[TBL] [Abstract][Full Text] [Related]
13. [A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation].
Dejaco C; Duftner C; Wipfler E; Schirmer M
Wien Med Wochenschr; 2009; 159(3-4):70-5. PubMed ID: 19247593
[TBL] [Abstract][Full Text] [Related]
14. [Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis].
Harigai M
Clin Calcium; 2007 Apr; 17(4):577-84. PubMed ID: 17404488
[TBL] [Abstract][Full Text] [Related]
15. T-cell agents in the treatment of rheumatoid arthritis - 2011 update.
Solomon GE
Bull NYU Hosp Jt Dis; 2011; 69(3):230-2. PubMed ID: 22035434
[No Abstract] [Full Text] [Related]
16. Abatacept mechanism of action: concordance with its clinical profile.
Herrero-Beaumont G; Martínez Calatrava MJ; Castañeda S
Reumatol Clin; 2012; 8(2):78-83. PubMed ID: 22104048
[TBL] [Abstract][Full Text] [Related]
17. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
18. What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials.
Smolen JS
J Rheumatol Suppl; 2007 Jul; 79():15-20. PubMed ID: 17611974
[TBL] [Abstract][Full Text] [Related]
19. The inhibitor of costimulation of T cells: abatacept.
Iannone F; Lapadula G
J Rheumatol Suppl; 2012 Jul; 89():100-2. PubMed ID: 22751606
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?
Pollard LC
Drugs; 2007; 67(1):1-9. PubMed ID: 17209660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
